As Senior Health and Research Officer, Laura is involved in the management of EU-funded projects that can benefit the lives of cancer patients and establishes good communication and working relationships with key stakeholders.
Laura studied Biology in the Universidad Complutense de Madrid and received her PhD in Biological Sciences working at the Human Cancer Genetics Program at the Spanish National Cancer Centre (CNIO, Madrid), where she identified and validated new target genes in cancer in combination with antitumor drug testing. Subsequently, she completed two postdoctoral trainings in New York to identify and validate new actionable targets in breast cancer in combination with antitumor drug testing (Mount Sinai School of Medicine) and to characterize somatic mosaic mutations in neurodevelopmental pediatric diseases (Rockefeller University). During her most recent academic period at the Vrije Universiteit of Brussel (VUB, Brussels), she led a project granted with an individual Marie Skłodowska-Curie fellowship that focused on women’s health.
Laura has always been interested in understanding the molecular alterations underlying human diseases to improve the quality of life of patients, especially those with cancer-related conditions. She is now motivated to bring her expertise and experience in representing the needs of cancer patients in decision-making processes.
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.
Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages